10:18 AM EST - Acerus Pharmaceuticals Corporation : Has closed the previously announced amendment and restatement of the $5.0 million U.S. subordinated secured term loan facility previously entered into on July 19, 2019 between Acerus and First Generation Capital, Inc., a company affiliated with the Chairman of the Board of Directors of Acerus, to (i) increase the borrowed amount to $11.5 million U.S., (ii) extend the maturity date to June 30, 2021 and (iii) cap the total amount of interest payable to First Generation under the A&R Loan (including interest paid from the closing of the original $5.0 million U.S. subordinated secured term loan facility) to an amount equal to Cdn.$1,696,266.44. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.005 at $0.07.
